Orion Portfolio Solutions’s Royalty Pharma RPRX Stock Holding History

Orion Portfolio Solutions’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$286K	Buy	+9,189	New	+$291K	﹤0.01%	1651

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Orion Portfolio Solutions's RPRX Position: Q1 2025 in Review

Orion Portfolio Solutions opened a new position in Royalty Pharma (RPRX) in Q1 2025: 9,189 shares worth $286K. The stake represents ﹤0.01% of the portfolio and ranks #1651 among its holdings.

447 funds tracked by Wall St. Rank hold RPRX as of Q1 2025.

Orion Portfolio Solutions held 9,189 shares of Royalty Pharma worth $286K as of Q1 2025.
Royalty Pharma was a new Orion Portfolio Solutions position in Q1 2025.
Royalty Pharma made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1651 holding.
447 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.